Asset 17
Skip to content
Continuing Education
Online Orders
Continuing Education
Online Orders
Asset 17
  • Home
  • Services
  • Facilities
  • Software
  • Clinical Trials
  • Contact

Press Release

Press Release Articles

2 Articles

UPPI to partner with Telix on development of new Prostate Cancer Imaging Agent

Telix Pharmaceuticals Limited (ASX: TLX) is a global biopharmaceutical company based in Melbourne. The company develops...

Read More

Amyloid PET changed clinical management in 60% of patients with dementia

Amyloid PET imaging greatly influenced the clinical management of patients with mild cognitive impairment (MCI)...

Read More

Asset 17
  • Home
  • Services
  • Facilities
  • Software
  • Clinical Trials
  • Contact

©2021 Shertech Nuclear. All rights reserved.   |  Sitemap

Web Design by: Drum Creative
Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok